vs

Side-by-side financial comparison of Enact Holdings, Inc. (ACT) and National Vision Holdings, Inc. (EYE). Click either name above to swap in a different company.

National Vision Holdings, Inc. is the larger business by last-quarter revenue ($487.3M vs $312.7M, roughly 1.6× Enact Holdings, Inc.). On growth, National Vision Holdings, Inc. posted the faster year-over-year revenue change (7.9% vs 3.6%). Over the past eight quarters, National Vision Holdings, Inc.'s revenue compounded faster (7.6% CAGR vs 3.6%).

Enact Holdings, Inc. is a leading U.S.-based private mortgage insurance provider. It delivers risk mitigation solutions to residential mortgage lenders, banks, and credit unions, enabling borrowers with smaller down payments to access affordable home financing, and supports sustainable homeownership for diverse consumer groups across the United States.

Vision Research is an international company that manufactures high-speed digital cameras based in Wayne, New Jersey. Their cameras are marketed under the Phantom brand, and are used in a broad variety of industries including: defense, industrial product development, manufacturing, automotive, scientific research, and entertainment. Vision Research is a business unit of the Materials Analysis Division of Ametek Inc., a global manufacturer of electronic instruments and electromechanical devices.

ACT vs EYE — Head-to-Head

Bigger by revenue
EYE
EYE
1.6× larger
EYE
$487.3M
$312.7M
ACT
Growing faster (revenue YoY)
EYE
EYE
+4.3% gap
EYE
7.9%
3.6%
ACT
Faster 2-yr revenue CAGR
EYE
EYE
Annualised
EYE
7.6%
3.6%
ACT

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ACT
ACT
EYE
EYE
Revenue
$312.7M
$487.3M
Net Profit
$3.4M
Gross Margin
Operating Margin
71.3%
2.0%
Net Margin
0.7%
Revenue YoY
3.6%
7.9%
Net Profit YoY
139.8%
EPS (diluted)
$1.23
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACT
ACT
EYE
EYE
Q4 25
$312.7M
Q3 25
$311.5M
$487.3M
Q2 25
$304.9M
$486.4M
Q1 25
$306.8M
$510.3M
Q4 24
$301.8M
$437.3M
Q3 24
$309.6M
$451.5M
Q2 24
$298.8M
$451.7M
Q1 24
$291.6M
$482.8M
Net Profit
ACT
ACT
EYE
EYE
Q4 25
Q3 25
$3.4M
Q2 25
$8.7M
Q1 25
$14.2M
Q4 24
$-28.6M
Q3 24
$-8.5M
Q2 24
$-3.1M
Q1 24
$11.7M
Operating Margin
ACT
ACT
EYE
EYE
Q4 25
71.3%
Q3 25
67.4%
2.0%
Q2 25
70.4%
3.4%
Q1 25
68.9%
5.1%
Q4 24
68.9%
-5.8%
Q3 24
74.1%
-2.0%
Q2 24
78.6%
0.1%
Q1 24
70.6%
4.9%
Net Margin
ACT
ACT
EYE
EYE
Q4 25
Q3 25
0.7%
Q2 25
1.8%
Q1 25
2.8%
Q4 24
-6.5%
Q3 24
-1.9%
Q2 24
-0.7%
Q1 24
2.4%
EPS (diluted)
ACT
ACT
EYE
EYE
Q4 25
$1.23
Q3 25
$1.10
$0.04
Q2 25
$1.11
$0.11
Q1 25
$1.08
$0.18
Q4 24
$1.05
$-0.36
Q3 24
$1.15
$-0.11
Q2 24
$1.16
$-0.04
Q1 24
$1.01
$0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACT
ACT
EYE
EYE
Cash + ST InvestmentsLiquidity on hand
$582.5M
$56.0M
Total DebtLower is stronger
$744.5M
$236.5M
Stockholders' EquityBook value
$5.4B
$858.8M
Total Assets
$6.9B
$2.0B
Debt / EquityLower = less leverage
0.14×
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACT
ACT
EYE
EYE
Q4 25
$582.5M
Q3 25
$545.6M
$56.0M
Q2 25
$616.0M
$48.5M
Q1 25
$639.0M
$80.0M
Q4 24
$602.8M
$73.9M
Q3 24
$674.9M
$81.2M
Q2 24
$711.3M
$179.5M
Q1 24
$624.3M
$150.1M
Total Debt
ACT
ACT
EYE
EYE
Q4 25
$744.5M
Q3 25
$744.1M
$236.5M
Q2 25
$743.8M
$255.6M
Q1 25
$743.4M
$244.7M
Q4 24
$743.0M
$248.6M
Q3 24
$742.7M
$252.8M
Q2 24
$742.4M
$143.9M
Q1 24
$746.1M
$448.6M
Stockholders' Equity
ACT
ACT
EYE
EYE
Q4 25
$5.4B
Q3 25
$5.3B
$858.8M
Q2 25
$5.2B
$850.6M
Q1 25
$5.1B
$836.2M
Q4 24
$5.0B
$816.3M
Q3 24
$5.0B
$840.0M
Q2 24
$4.8B
$843.4M
Q1 24
$4.7B
$841.3M
Total Assets
ACT
ACT
EYE
EYE
Q4 25
$6.9B
Q3 25
$6.9B
$2.0B
Q2 25
$6.8B
$2.0B
Q1 25
$6.7B
$2.0B
Q4 24
$6.5B
$2.0B
Q3 24
$6.6B
$2.0B
Q2 24
$6.3B
$2.1B
Q1 24
$6.3B
$2.2B
Debt / Equity
ACT
ACT
EYE
EYE
Q4 25
0.14×
Q3 25
0.14×
0.28×
Q2 25
0.14×
0.30×
Q1 25
0.15×
0.29×
Q4 24
0.15×
0.30×
Q3 24
0.15×
0.30×
Q2 24
0.15×
0.17×
Q1 24
0.16×
0.53×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACT
ACT
EYE
EYE
Operating Cash FlowLast quarter
$724.5M
$46.6M
Free Cash FlowOCF − Capex
$30.3M
FCF MarginFCF / Revenue
6.2%
Capex IntensityCapex / Revenue
3.4%
Cash ConversionOCF / Net Profit
13.83×
TTM Free Cash FlowTrailing 4 quarters
$83.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACT
ACT
EYE
EYE
Q4 25
$724.5M
Q3 25
$192.0M
$46.6M
Q2 25
$119.5M
$54.3M
Q1 25
$226.7M
$32.2M
Q4 24
$686.3M
$30.3M
Q3 24
$188.1M
$27.9M
Q2 24
$144.7M
$51.5M
Q1 24
$187.3M
$24.0M
Free Cash Flow
ACT
ACT
EYE
EYE
Q4 25
Q3 25
$30.3M
Q2 25
$42.4M
Q1 25
$12.0M
Q4 24
$-1.7M
Q3 24
$4.1M
Q2 24
$31.9M
Q1 24
$4.0M
FCF Margin
ACT
ACT
EYE
EYE
Q4 25
Q3 25
6.2%
Q2 25
8.7%
Q1 25
2.4%
Q4 24
-0.4%
Q3 24
0.9%
Q2 24
7.1%
Q1 24
0.8%
Capex Intensity
ACT
ACT
EYE
EYE
Q4 25
Q3 25
3.4%
Q2 25
2.4%
Q1 25
4.0%
Q4 24
7.3%
Q3 24
5.3%
Q2 24
4.3%
Q1 24
4.1%
Cash Conversion
ACT
ACT
EYE
EYE
Q4 25
Q3 25
13.83×
Q2 25
6.22×
Q1 25
2.27×
Q4 24
Q3 24
Q2 24
Q1 24
2.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons